First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease

Abstract The combination of rifamycin (RFP), ethambutol (EB), and macrolides is currently the standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). However, poor adherence to the standardized regimens recommended by current guidelines have been reported. We undert...

Full description

Saved in:
Bibliographic Details
Main Authors: Kiyoharu Fukushima, Seigo Kitada, Sho Komukai, Tomoki Kuge, Takanori Matsuki, Hiroyuki Kagawa, Kazuyuki Tsujino, Mari Miki, Keisuke Miki, Hiroshi Kida
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/3a2e1baa63ee4ff4a81f0ec6b2a4718d
Tags: Add Tag
No Tags, Be the first to tag this record!